Kraig Biocraft Laboratories Inc. (OTC:KBLB) Stock In Focus After Recent News
This morning, most investors are going to track the stocks of those companies that may have been in the news cycle on Monday, and hence, Kraig Biocraft Laboratories Inc. (OTC:KBLB) could well be the stock to follow. On April 22, the company came into focus after it announced that it had hit a significant new milestone. Kraig Biocraft Laboratories announced that it had been successful in concluding the rearing of the first generation of its BAM-1 parental strains. The strains had been reared as part of the company’s spring production trial.
It was also announced that the company had been successful in producing cocoon at rates that had surpassed all the control benchmarks and expectations for the trials. The company brought in Dr. Nirmal Kumar, a leading independent sericulture expert, to guide and supervise the trials. In the aforementioned trials, the company was successful in completing the highly important critical stage for both the parental strains pertaining to the BAM 1 hybrid.
Each of the parental strains had been divided into two separate batches, and that led to the creation of four distinct production trial groups. Kraig Biocraft Laboratories noted that the results from the trails had proven to be an unqualified success, and all four different production batches had clocked impressive growth rates along with almost perfect cocooning.
Dr. Kumar, who had supervised the trials, spoke about the operation as well. He stated that he was considerably impressed with the strength of the BAM-1 parental lines. Moreover, the colony had also demonstrated robust health and fast growth.
The rearing skills of the Kraig Biocraft Laboratories team were also progressing fast and were in the right place to begin boosting production. In light of the latest development, it could be a good move for investors to add Kraig Biocraft Laboratories to their watch lists.
